anonymous
Guest
anonymous
Guest
Our last life-line will be gone very soon. Losing this revenue would mean at least 50% cuts to the HO and sales. Get out as soon as possible, good luck to everyone!
Yeah, we know. It was posted on here weeks ago. Look under any "layoff" thread.Our last life-line will be gone very soon. Losing this revenue would mean at least 50% cuts to the HO and sales. Get out as soon as possible, good luck to everyone!
looks like more delays
It “might “ get FDA approval but not a single payer will cover it ! So not gonna help bottom line .
this is almost all of our revenue and when it goes so do we
You are spot on - he is doing such a lousy job. The stalk is at a all time low, we are so overstaffed and I can t believe how bad the pipeline is.
Thanks for the heads up
You are spot on - he is doing such a lousy job. The stalk is at a all time low, we are so overstaffed and I can t believe how bad the pipeline is.
Thanks for the heads up
The patent is until October 2022. I doubt that Welchol would produce a generic any time soon. The oral suspension version only started back in 2009.
he’s even worse a big mouth frenchieSo many resources and $ wasted in R&D. Gormley needs to be shown the door and get someone who can produce. I hear the new guy is a real winner.
The patent is until October 2022. I doubt that Welchol would produce a generic any time soon. The oral suspension version only started back in 2009.